EXEL — Exelixis Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for Exelixis, fiscal year end - January 3rd, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 30th	2023 December 29th	2025 January 3rd
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,207	1,467	1,308	995	1,111
Net Total Accounts Receivable
Net Total Receivables	161	283	215	237	265
Total Inventory
Prepaid Expenses
Total Current Assets	1,445	1,835	1,619	1,318	1,468
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	110	149	345	362	292
Net Goodwill
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,137	2,616	3,071	2,942	2,948
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	205	338	324	394	404
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	258	406	583	678	703
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,879	2,211	2,488	2,264	2,244
Total Liabilities & Shareholders' Equity	2,137	2,616	3,071	2,942	2,948
Total Common Shares Outstanding